T he interaction of circulating neutrophils with vascular endothelium is a critical phenomenon in several pathological circumstances.12 Neutrophil accumulation on the endothelial surface of blood vessels may lead to alterations in blood flow, changes in vascular permeability, and endothelial injury. However, a whole picture of the mechanisms involved in such phenomena is still unavailable, and several relevant aspects remain to be clarified.
Endothelin-1 is a potent vasoconstrictor peptide synthesized by endothelial cells3; it is highly expressed in several pathological circumstances, eg, myocardial and renal ischemia4'5 and atherosclerosis,6 which also involve interaction between polymorphonuclear or mononuclear leukocytes and the endothelium. Recently, studies from several laboratories including ours have found a significant effect of endothelin-1 on neutrophils by increasing intracellular free calcium mobilization,7 N-formyl-L-methyonil-L-leucyl-L-phenylalanine (fMLP)-mediated superoxide anion production,8 or aggregation. 9 Based on the above-mentioned data about the effects of endothelin-1 on neutrophils, we hypothesized that a significant effect of endothelin-1 on neutrophil adhesiveness was likely to occur. The general mechanisms for the adhesion of neutrophils to endothelial cells have been extensively studied in recent years (see References 10 and 11 for review). Briefly, neutrophil activation results in the expression or activation of surface adhesive proteins, which are members of the glycoprotein-adhesive complex CD11/CD18 (see References 12, 13 , and 16 for review). The CD11/CD18 adhesion complex is a family of three heterodimers, each consisting of a common f-polypeptide chain and a variable a-chain. These To further address the individual role of neutrophilrelated or endothelium-related mechanisms in the adhesion phenomenon, two additional experiments were performed: (1) neutrophil adhesion to the endothelium was examined after preincubation (10 minutes) of the endothelial cells with endothelin-1 (10-`); endothelin-1 was washed offwith fresh Krebs buffer (37°C, 5 times), and the assay was performed in Krebs containing no endothelin-i; (2) similar neutrophil adhesion experiments were carried out on a plastic surface (tissue culture dish 35 x 10 mm, Costar, Cambridge, Mass) both in the presence and absence of endothelin-i. Furthermore, adhesion experiments were done in the presence of other pressor hormones, namely, arginine vasopressin (10-mol/L) or angiotensin II (i0-`mol/L), to examine the specificity of the observed endothelin-1 effect.
For immunofluorescence flow cytometry assays, the neutrophils were incubated with the monoclonal antibodies against the CD18 or CD11 antigens followed by a second incubation with a fluorescein isothyocyanateconjugated goat anti-mouse IgG (The Binding Site, Birmingham, England).18,19 The fluorescence was measured by using an EPICS flow cytometer/sorter (Coulter) at 480-nm excitation and 520-nm emission. A minimum of 6000 cells were analyzed for each sample. The data were displayed as one-parameter histograms plotting the logarithm of the green fluorescence vs cell number.
Monoclonal Antibodies
The monoclonal antibodies used in these studies have been described elsewhere.17 These antibodies recognize different epitopes on the a-and ,B-integrin chains as follows: the anti-CD18 was TS1/18, the anti-LFA-1-a (CDiia) was TS1/11 and TP1/32, the anti-Mac-1 (CD11b) was Bear-1, and the anti-plS0,95 (CDiic) was HC1/1. P3X63 myeloma culture supernatant was used as negative control.
Isolated Heart Experiments
Healthy male rabbits weighing approximately 1.9±0.6 kg were anesthetized with sodium pentobarbital (100 mg/kg body wt IP). The chest was opened, and the sternum and ventral portions of the ribs were removed to expose the heart and lungs. The aorta was cannulated with a 21-gauge needle, and the tip of the cannula was placed approximately 3 mm above the aortic valve. The heart was quickly removed and placed into a thermostatized (37°C), oxygenated (95% 02, 5% C02), siliconized glass beaker, which contained Krebs solution supplemented with 5 mol/L glucose and 5% bovine serum albumin. The heart was externally and internally washed, and the coronary circulation was perfused until a uniform pale color was obtained. Thereafter, endothelin-1 solution (0.027 ,ug/min in Krebs solution) was perfused during 30 minutes at a rate of 0.1 mL/min. The endothelin-1 dose was selected according to previous reports showing that doses lower than 0.3 jig did not produce a significant in vivo coronary vasoconstrictor effect.20 Two minutes after the beginning of the endothelin-1 infusion, 5`Cr-labeled rabbit neutrophils in sterile Krebs buffer (8x10' in 0.5 mL, 79 995+± 10 354 cpm/8x 106 cells) were injected as a bolus. Additional estimated from the radioactivity of a control sample. Results were expressed as the number of neutrophils experiments were performed by preincubating (10 minutes) the 5`Cr-labeled neutrophils with the monoclonal antibody TS1/18 or with the nonspecific antibody P3X63.
The perfusion system was closed by a catheter connected from the perfusion Krebs solution to the aortic cannula, using a flow pump. Through this catheter, the perfusate from the heart returned continuously to the organ during the whole experiment. The experiment was stopped by washing out the nonadherent neutrophils with fresh Krebs buffer. The hearts were homogenized in 10% TCA (6 mL), divided into polystyrene tubes, and counted in a gamma counter. As a control of the specificity of neutrophil accumulation, additional experiments were done using 51Cr-labeled erythrocytes (packed cell volume, 30% in the Krebs buffer; 295 035 ±36 550 cpm) instead of neutrophils. As a further control for the role of neutrophil isospecificity or heterospecificity in the observed phenomena, additional experiments were done using human instead of rabbit neutrophils.
In Vivo Experiments: Myeloperoxidase Activity Measurement
Under ketamine (10 mg/kg body wt) and xilazyne (20 mg/kg body wt IV) anesthesia and mechanical ventilation (Harvard miniature animal ventilator, Edenbridge, Kent, England), tracheostomized rabbits with characteristics similar to those described above were surgically prepared for exposure of the left atrium, which was used as the mixing chamber. A 22-gauge needle connected to an infusion pump was inserted into the left atrium and tied up. A continuous infusion of physiological saline solution (PSS; in mmol/L: NaCl 137, KCl 2.6, KH2PO4 1.5, NaH2PO4 8, glucose 5.6) (0.1 mL/min, 37°C) was then administered during a 30-minute equilibration period. At the end of the equilibration, either endothelin-1 (0.027 ,ug/min) or PSS alone was infused for an additional 30 minutes. Once this second infusion was finished, the animals were given an overdose of anesthetic, and the heart, lungs, and kidneys were perfused and washed with PSS. Immediately after, the organs were frozen in liquid nitrogen for myeloperoxidase activity determination.
Myeloperoxidase activity measurements were performed after homogenizing the tissues in 50 mmol/L of potassium phosphate buffer, pH 6.0, containing 0.5% hexadecyltrimethylammonium bromide. The homogenized tissue was freeze-thawed three times and centrifuged; after centrifugation, the supernatant (0.2 mL) was mixed with 2.9 mL of 50 mmol/L of potassium phosphate buffer, pH 6.0, containing 0.167 mg/mL of o-dianisidine dihydrochloride and 0.5% hydrogen peroxide. The myeloperoxidase activity was measured as the change in absorbance at 460 nm. One unit of myeloperoxidase was defined as the amount of sample degrading 1 
Stimulation of Neutrophil Adhesion by Endothelin
Endothelin-1 (10-`mol/L) stimulated human 51Cr-neutrophil adherence to bovine endothelial cells (Fig 1) .
The endothelin-1-induced neutrophil adhesion was equivalent to that provoked by the known chemoattractant peptide fMLP (10-7 mol/L) and smaller than the adhesion induced by a full dose of the phorbol ester PMA (10-6 mol/L) (Fig 1) . The dose of endothelin-1 was chosen based on previous studies in which 10 `mol/L endothelin-1 consistently provoked a peak of cytosolic free calcium. 7 In addition, an increased neutrophil adhesion was observed by using 10-8 and 10-`mol/L endo- :t examined by performing the adhesion assay in the presence of the specific monoclonal antibody TS1/18, directed against the common 13-subunit. As shown in Fig  2, the blockade of the 13-chain of the integrin complex blunted the endothelin-1-stimulated neutrophil adhesion. No effect of the nonspecific antibody P3X63 was detected on endothelin-1-induced neutrophil adherence (2±1.4% blockade, P=NS).
Once the CD11/CD18 complex was identified as the putative mediator of the endothelin-1-induced neutrophil-endothelium interaction, we examined which of the a-subunits was possibly involved in this process. As shown in Fig 2, a significant inhibition of the endothelin-1-induced neutrophil adhesion to endothelial cells was observed with anti-CD11a, anti-CD11b, and antiCD11c monoclonal antibodies. The inhibition of binding caused by anti-CD11a, anti-CD11b, and anti-CDt1c was partial. The inhibition observed by TS1/18 was nearly complete (about 80% to 90%), suggesting that CD11a/CD18, CD11b/CD18, or CD11c/CD18 has a function in adhesion of endothelin-1-stimulated neutrophils to endothelial cells. This was confirmed by the observation that a mixture of monoclonal antibodies against LFA-1, Mac-1, and p150,95 had an additive inhibitory effect on the neutrophil adhesion (Fig 2) .
Analysis by flow cytometry demonstrated that endothelin-1 (n=4) increased the expression of the CD18 ,B-integrin common subunit in a similar degree to that induced by fMLP (Fig 3A) . An increased expression of CD11b was also observed in the presence of endothelin-1 (Fig 3B) , whereas no significant effect of endothelin-1 was detected on the surface expression of CD11a and CD11c (data not shown). 
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Neutrophil Adhesion to Perfused Heart
Endothelin-1 infusion markedly increased the accumulation of rabbit neutrophils on the isolated perfused rabbit heart (unstimulated neutrophil accumulation: 1.5x 106±+1.6x 105; endothelin-1-stimulated neutrophils: 4.2x 106±3.8x 105 neutrophils; n=5, P<.01). No changes in the coronary perfusion pressure were detected with the dose of 0.027 ,ug/min endothelin-1 (perfusion pressure, 100±21 and 104±26 mm Hg in the absence and presence of endothelin-1, respectively, P=NS). Moreover, in order to discard a nonspecific trapping of neutrophils induced by any undetected vasoconstrictor effect of endothelin-1, two additional experiments were carried out: (1) Neutrophils were incubated with the monoclonal antibody against the CD18 antigen TS1/18 from 10 minutes before and throughout the infusion into the coronary circulation. TS1/18 inhibited endothelin-1-induced neutrophil accumulation by 65±15% (P<.01), therefore indicating a significant involvement of the CD11/CD18 complex. No inhibition of the endothelin-1-stimulated neutrophil accumulation was found by preincubating the neutrophils with the nonbinding monoclonal antibody P3X63 (percent inhibition, 1.2+0.8; P=NS). (2) 5`Cr-labeled erythrocytes were infused both in the presence (n=3) and the absence of endothelin-1 (n=3). No differences were detected in the accumulated 5`Cr radioactivity, depending on the absence or presence of endothelin-1 (total`'Cr, 20 313±1300 and 23 110±1810 cpm per gram of heart, respectively; P=NS). In all of the comparative experiments, cells from the same batch of 1Cr-labeled neutrophils or erythrocytes were used.
To rule out any possible nonspecific interaction between TS1/18 and rabbit neutrophils, additional experiments were carried out by preincubating human neutrophils with TS1/18 before infusing them into the rabbit heart (n=3). Endothelin-1 stimulated human neutrophil accumulation in the isolated rabbit heart in a degree similar to that observed by using rabbit neutrophils (increase of human neutrophil accumulation, 3.01 x 106+ 3.01x 10 neutrophils; n=4, P<.05). This effect was inhibited (62±12% inhibition; n=3, P<.05 with respect to endothelin-1 alone) by coinfusion with TS1/18. In Vivo Neutrophil Accumulation in Endothelin-1-Infused Rabbits
The intra-atrial administration of endothelin-1 induced a significant increase of the activity of the neutrophil-specific enzyme myeloperoxidase in the rabbit heart (Table) . A significant albeit smaller increase of myeloperoxidase activity in the rabbit kidneys and no changes of myeloperoxidase activity in the rabbit lungs also were observed (Table) . These results confirmed that endothelin-1 was capable of inducing neutrophil accumulation in in vivo conditions. No changes in systemic arterial pressure were detected with the intracardiac administration of this dose (0.027 ,ug/min) of endothelin-1 (increase in mean arterial pressure, 4±1.8 mm Hg; P=NS).
Discussion
The complete in vivo functions of endothelin-1 are still insufficiently defined. Several studies have shown that circulating immunoreactive endothelin-1 levels are elevated in conditions in which the interaction between neutrophils and endothelium is especially relevant, eg, myocardial ischemia.4,22.23 However, no reports have been published to date about the possible relation between the high endothelin-1 levels and the functional properties of the neutrophils, eg, adhesiveness. The present results may contribute to the understanding of the actual pathophysiological role of endothelin-1. For the first time, endothelin-1 and organ accumulation of neutrophils are shown to be related.
First we found that endothelin-1 induced neutrophil adhesion to the endothelium. The endothelin-1 concentrations that provoked neutrophil adhesion were higher than the reported endothelin-1 plasma levels. However, the local tissue levels of endothelin-1 during ischemia are necessarily much higher than those measured in blood samples in ischemic conditions. 24 Several other aspects of the endothelin-1-induced neutrophil adhesion were clarified in the present series of experiments. The adhesion to plastic surfaces, the lack of effect of endothelial cell preincubation with endothelin-1, and the adhesive effect of endothelin-1 using human neutrophils and human endothelium illustrated the predominant effect of endothelin-1 on the neutrophil side of the adhesion phenomenon and the absence of a nonspecific effect due to species heterogeneity. The specificity of endothelin-1 as an adhesioninducing agent was additionally substantiated by the experiments showing the absence of action of either angiotensin II or arginine vasopressin.
More information was obtained from the isolated heart perfusion and intra-atrial in vivo infusions. In this regard, both the blockade of neutrophil accumulation in the perfused heart by TS1/18 and the absence of labeled erythrocyte accumulation suggested that endothelin-1-induced neutrophil accumulation on the heart corresponds to a specific integrin-mediated phenomenon. Moreover, an effect of endothelin-1 on neutrophil accumulation in the kidney was detected in the in vivo experiments. This finding is further supported by isolated kidney perfusion experiments done in our laboratory showing an increased neutrophil accumulation in the presence of endothelin-1.26 Of further interest, an increased myeloperoxidase activity, which was inhibitable by the administration of anti-endothelin-1 antibody, has been detected in the hearts of rabbits submitted to 1 hour of renal ischemia (Espinosa et al, unpublished observations), therefore opening the possibility of heart effects of ischemic phenomena occurring in distant organs. The lack of effect of endothelin-1 on neutrophil accumulation in the lungs in the present experimental conditions could be due to either a decreased amount of endothelin-1 reaching the lungs or to the high endothelinase activity found in the pulmonary circulation. 27 Further experiments are necessary to reveal the complete mechanisms and in vivo pathophysiological consequences of these findings. In particular, the question should be raised about the actual role of endothelin-1 in neutrophil accumulation during the reperfusion phase that follows coronary ischemia.
